| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Mucosa | 19 | 2024 | 51 | 3.520 |
Why?
|
| Cell Differentiation | 14 | 2021 | 398 | 3.320 |
Why?
|
| Epithelial Cells | 15 | 2024 | 240 | 2.620 |
Why?
|
| Bronchi | 6 | 2021 | 38 | 2.300 |
Why?
|
| Receptor, Notch3 | 4 | 2022 | 15 | 1.830 |
Why?
|
| Viral Proteins | 8 | 2010 | 62 | 1.250 |
Why?
|
| Herpesvirus 3, Human | 6 | 2010 | 12 | 1.240 |
Why?
|
| Smoking | 8 | 2017 | 466 | 1.230 |
Why?
|
| Receptors, Notch | 3 | 2022 | 44 | 1.200 |
Why?
|
| Epithelium | 3 | 2017 | 39 | 1.200 |
Why?
|
| Smoke | 2 | 2021 | 33 | 1.180 |
Why?
|
| Endothelial Cells | 5 | 2021 | 340 | 1.180 |
Why?
|
| Lung | 5 | 2023 | 360 | 1.160 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2021 | 62 | 1.100 |
Why?
|
| Signal Transduction | 10 | 2022 | 1374 | 1.090 |
Why?
|
| Cigarette Smoking | 3 | 2021 | 76 | 0.940 |
Why?
|
| Lung Diseases | 2 | 2022 | 42 | 0.900 |
Why?
|
| Immediate-Early Proteins | 6 | 2010 | 15 | 0.870 |
Why?
|
| Immunity, Innate | 2 | 2025 | 211 | 0.860 |
Why?
|
| Biological Phenomena | 1 | 2022 | 4 | 0.820 |
Why?
|
| Cells, Cultured | 13 | 2021 | 975 | 0.780 |
Why?
|
| Goblet Cells | 1 | 2021 | 14 | 0.740 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 54 | 0.740 |
Why?
|
| Repressor Proteins | 1 | 2021 | 114 | 0.720 |
Why?
|
| Tobacco Products | 2 | 2021 | 189 | 0.720 |
Why?
|
| Humans | 40 | 2025 | 27127 | 0.710 |
Why?
|
| Histone Deacetylase 2 | 2 | 2010 | 10 | 0.690 |
Why?
|
| Basement Membrane | 2 | 2017 | 6 | 0.640 |
Why?
|
| Cellular Senescence | 2 | 2021 | 121 | 0.610 |
Why?
|
| Paracrine Communication | 2 | 2015 | 16 | 0.590 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 145 | 0.590 |
Why?
|
| Gene Expression Profiling | 8 | 2018 | 438 | 0.590 |
Why?
|
| Herpesvirus 2, Saimiriine | 4 | 2005 | 4 | 0.590 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 41 | 0.550 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 6 | 0.540 |
Why?
|
| Virus Replication | 4 | 2025 | 62 | 0.530 |
Why?
|
| Transcriptional Activation | 3 | 2005 | 86 | 0.520 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 93 | 0.520 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2015 | 3 | 0.500 |
Why?
|
| Receptor, Notch1 | 1 | 2015 | 26 | 0.480 |
Why?
|
| Cilia | 4 | 2017 | 41 | 0.470 |
Why?
|
| Cell Culture Techniques | 2 | 2024 | 115 | 0.470 |
Why?
|
| Stem Cells | 4 | 2016 | 113 | 0.460 |
Why?
|
| Trans-Activators | 4 | 2016 | 114 | 0.460 |
Why?
|
| Multipotent Stem Cells | 1 | 2013 | 5 | 0.450 |
Why?
|
| Cell Line | 9 | 2020 | 679 | 0.440 |
Why?
|
| Promoter Regions, Genetic | 3 | 2005 | 333 | 0.430 |
Why?
|
| Transcriptome | 3 | 2021 | 205 | 0.430 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2010 | 70 | 0.410 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 627 | 0.410 |
Why?
|
| Herpes Zoster | 2 | 2009 | 20 | 0.410 |
Why?
|
| Viral Envelope Proteins | 2 | 2010 | 5 | 0.390 |
Why?
|
| Cell Nucleus | 2 | 2010 | 135 | 0.370 |
Why?
|
| Antigens, Nuclear | 2 | 2010 | 22 | 0.370 |
Why?
|
| Adult | 10 | 2021 | 7494 | 0.370 |
Why?
|
| Case-Control Studies | 6 | 2021 | 706 | 0.370 |
Why?
|
| Alphaherpesvirinae | 1 | 2010 | 1 | 0.360 |
Why?
|
| Male | 11 | 2021 | 13008 | 0.350 |
Why?
|
| Interferons | 2 | 2021 | 68 | 0.350 |
Why?
|
| RING Finger Domains | 1 | 2010 | 1 | 0.350 |
Why?
|
| Histone Deacetylase 1 | 1 | 2009 | 10 | 0.330 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2021 | 60 | 0.330 |
Why?
|
| Autoantigens | 2 | 2010 | 212 | 0.330 |
Why?
|
| Animals | 9 | 2025 | 10065 | 0.300 |
Why?
|
| Female | 10 | 2021 | 14625 | 0.300 |
Why?
|
| Amino Acid Sequence | 5 | 2010 | 674 | 0.290 |
Why?
|
| Cell Proliferation | 4 | 2021 | 773 | 0.290 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 1036 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 324 | 0.280 |
Why?
|
| RNA Interference | 2 | 2017 | 135 | 0.270 |
Why?
|
| Neurons | 1 | 2008 | 274 | 0.260 |
Why?
|
| Aged | 3 | 2021 | 5217 | 0.260 |
Why?
|
| Coculture Techniques | 2 | 2017 | 54 | 0.260 |
Why?
|
| Middle Aged | 6 | 2021 | 6901 | 0.250 |
Why?
|
| Response Elements | 2 | 2005 | 21 | 0.250 |
Why?
|
| Receptors, Steroid | 1 | 2025 | 26 | 0.240 |
Why?
|
| AT-Hook Motifs | 1 | 2004 | 1 | 0.230 |
Why?
|
| Antiviral Agents | 1 | 2025 | 111 | 0.230 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 38 | 0.230 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 34 | 0.230 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2023 | 6 | 0.220 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 14 | 0.220 |
Why?
|
| Hyperoxia | 1 | 2024 | 78 | 0.210 |
Why?
|
| Papio | 1 | 2023 | 78 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 93 | 0.200 |
Why?
|
| DNA Methylation | 4 | 2017 | 150 | 0.200 |
Why?
|
| Mammals | 1 | 2022 | 46 | 0.200 |
Why?
|
| Air | 1 | 2021 | 23 | 0.190 |
Why?
|
| Tissue Donors | 1 | 2021 | 24 | 0.190 |
Why?
|
| Cell Death | 1 | 2021 | 111 | 0.190 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 29 | 0.190 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 195 | 0.180 |
Why?
|
| Extracellular Vesicles | 1 | 2021 | 35 | 0.180 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2020 | 6 | 0.170 |
Why?
|
| Phosphorylation | 3 | 2010 | 566 | 0.170 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 474 | 0.170 |
Why?
|
| Smokers | 1 | 2021 | 123 | 0.170 |
Why?
|
| Influenza A virus | 1 | 2020 | 29 | 0.170 |
Why?
|
| Genome, Human | 2 | 2017 | 71 | 0.160 |
Why?
|
| Up-Regulation | 2 | 2017 | 240 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 61 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2020 | 84 | 0.160 |
Why?
|
| Cytokines | 1 | 2021 | 438 | 0.160 |
Why?
|
| Biomarkers | 3 | 2020 | 736 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2016 | 506 | 0.140 |
Why?
|
| Inflammation | 1 | 2021 | 605 | 0.140 |
Why?
|
| Time Factors | 1 | 2021 | 1572 | 0.140 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2016 | 2 | 0.140 |
Why?
|
| Autophagy | 1 | 2017 | 70 | 0.130 |
Why?
|
| Gene Deletion | 2 | 2009 | 115 | 0.130 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 26 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2017 | 197 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 77 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2021 | 177 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 111 | 0.130 |
Why?
|
| RNA | 1 | 2017 | 105 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 57 | 0.130 |
Why?
|
| Immunity | 1 | 2016 | 26 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 482 | 0.130 |
Why?
|
| Fibroblast Growth Factor 5 | 1 | 2015 | 1 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 10 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 29 | 0.120 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 22 | 0.120 |
Why?
|
| Cell Line, Transformed | 2 | 2021 | 42 | 0.120 |
Why?
|
| Secretory Pathway | 1 | 2015 | 6 | 0.120 |
Why?
|
| DNA | 1 | 2017 | 365 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2015 | 60 | 0.120 |
Why?
|
| SOS1 Protein | 1 | 2014 | 2 | 0.120 |
Why?
|
| Ciliary Motility Disorders | 1 | 2014 | 2 | 0.120 |
Why?
|
| Metabolomics | 1 | 2016 | 82 | 0.120 |
Why?
|
| Proteins | 1 | 2017 | 245 | 0.120 |
Why?
|
| Ligands | 1 | 2015 | 168 | 0.120 |
Why?
|
| Telomere Shortening | 1 | 2014 | 4 | 0.120 |
Why?
|
| ras Proteins | 1 | 2014 | 43 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 106 | 0.120 |
Why?
|
| Tight Junctions | 1 | 2014 | 29 | 0.120 |
Why?
|
| Phenotype | 2 | 2013 | 665 | 0.120 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 115 | 0.120 |
Why?
|
| Telomere | 1 | 2014 | 32 | 0.120 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2014 | 3 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 283 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 109 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 8 | 0.110 |
Why?
|
| Retroviridae | 1 | 2013 | 16 | 0.110 |
Why?
|
| DNA Primers | 2 | 2012 | 143 | 0.110 |
Why?
|
| Aging | 1 | 2021 | 959 | 0.110 |
Why?
|
| Telomerase | 1 | 2013 | 37 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2014 | 78 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 123 | 0.110 |
Why?
|
| Open Reading Frames | 2 | 2005 | 38 | 0.110 |
Why?
|
| Transfection | 1 | 2013 | 312 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2014 | 647 | 0.100 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 11 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2013 | 514 | 0.100 |
Why?
|
| Respiratory System | 1 | 2011 | 13 | 0.090 |
Why?
|
| Liver | 1 | 2014 | 423 | 0.090 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2010 | 2 | 0.090 |
Why?
|
| Genes, Viral | 1 | 2010 | 9 | 0.090 |
Why?
|
| Vero Cells | 1 | 2010 | 12 | 0.090 |
Why?
|
| Virus Latency | 2 | 2008 | 9 | 0.090 |
Why?
|
| Herpesvirus 1, Human | 1 | 2010 | 24 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 130 | 0.090 |
Why?
|
| Protein Stability | 1 | 2010 | 42 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 102 | 0.090 |
Why?
|
| Simplexvirus | 1 | 2009 | 5 | 0.080 |
Why?
|
| Adolescent | 1 | 2017 | 2990 | 0.080 |
Why?
|
| Mutation | 2 | 2010 | 821 | 0.080 |
Why?
|
| Base Sequence | 1 | 2010 | 573 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 61 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2009 | 107 | 0.080 |
Why?
|
| Young Adult | 4 | 2019 | 2628 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 1268 | 0.080 |
Why?
|
| Luciferases, Renilla | 1 | 2008 | 1 | 0.080 |
Why?
|
| Cell Transformation, Viral | 1 | 2008 | 7 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 20 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 17 | 0.080 |
Why?
|
| Ganglia | 1 | 2008 | 9 | 0.080 |
Why?
|
| Glutathione Transferase | 1 | 2008 | 30 | 0.080 |
Why?
|
| Enteric Nervous System | 1 | 2008 | 10 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 50 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2009 | 147 | 0.080 |
Why?
|
| Guinea Pigs | 1 | 2008 | 73 | 0.080 |
Why?
|
| Obesity | 1 | 2014 | 651 | 0.080 |
Why?
|
| Adenoviridae | 1 | 2008 | 65 | 0.080 |
Why?
|
| Plasmids | 1 | 2008 | 121 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 80 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 229 | 0.070 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2004 | 12 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 1 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 4 | 0.060 |
Why?
|
| Virus Activation | 2 | 2005 | 9 | 0.060 |
Why?
|
| Trachea | 1 | 2024 | 25 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 129 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 188 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2014 | 238 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2017 | 630 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2024 | 851 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 55 | 0.050 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2020 | 14 | 0.040 |
Why?
|
| Airway Remodeling | 1 | 2019 | 1 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 131 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 50 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 240 | 0.040 |
Why?
|
| Reference Values | 1 | 2018 | 199 | 0.040 |
Why?
|
| Sequestosome-1 Protein | 1 | 2017 | 2 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2017 | 5 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 33 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 49 | 0.030 |
Why?
|
| Lysosomes | 1 | 2017 | 55 | 0.030 |
Why?
|
| Carboxyhemoglobin | 1 | 2016 | 3 | 0.030 |
Why?
|
| Sputum | 1 | 2016 | 7 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 10 | 0.030 |
Why?
|
| Cough | 1 | 2016 | 11 | 0.030 |
Why?
|
| Thorax | 1 | 2016 | 28 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 33 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 2016 | 47 | 0.030 |
Why?
|
| Cotinine | 1 | 2016 | 45 | 0.030 |
Why?
|
| Nicotine | 1 | 2016 | 82 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 119 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 71 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 128 | 0.030 |
Why?
|
| Axoneme | 1 | 2014 | 1 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2014 | 3 | 0.030 |
Why?
|
| Mice | 2 | 2014 | 4466 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 353 | 0.030 |
Why?
|
| Microtubules | 1 | 2014 | 89 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 22 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 37 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 119 | 0.030 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2013 | 3 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 9 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 467 | 0.030 |
Why?
|
| Weight Gain | 1 | 2014 | 73 | 0.030 |
Why?
|
| Adipocytes | 1 | 2014 | 55 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 134 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 399 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 118 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 129 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 254 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 455 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 340 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 38 | 0.020 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2009 | 1 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2009 | 24 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 101 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1405 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2009 | 50 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 49 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 188 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 245 | 0.020 |
Why?
|
| Codon, Initiator | 1 | 2005 | 6 | 0.020 |
Why?
|
| Binding Sites | 1 | 2005 | 341 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 635 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2001 | 50 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 310 | 0.010 |
Why?
|